Federal Register / Vol. 83, No. 177 / Wednesday, September 12, 2018 / Notices 46163 

an ‘‘HVCRE ADC Loan,’’ as defined in 

section 214 of EGRRCPA. Section 202 of 

EGRRCPA also amended the statutory 

definition of ‘‘brokered deposits.’’ The 

current instructions for reporting 

HVCRE and brokered deposits in the FR 

Y–9C are inconsistent with these 

provisions of EGRRCPA. 

In order to avoid the regulatory 

burden associated with different 

definitions for HVCRE exposures and 

brokered deposits within a single 

organization, the Board has amended 

the FR Y–9C instructions to permit bank 

holding companies, savings and loan 

holding companies, and intermediate 

holding companies of foreign banks to 

report HVCRE and brokered deposits on 

the FR Y–9C report in a manner 

consistent with their subsidiary 

depository institution(s). 

In order for the FR Y–9C to reflect 

sections 202 and 214 of EGRRCPA, 

which became effective immediately 

when EGRRCPA was signed on May 24, 

2018, the Board cannot comply with the 

normal clearance process and still 

receive the June 30, 2018, financial data 

in a timely manner. Therefore, the 

Board has determined that the revisions 

to the FR Y–9C described above must be 

instituted quickly and public 

participation in the approval process 

would substantially interfere with the 

Board’s ability to perform its statutory 

obligations arising from EGRRCPA. 

Board of Governors of the Federal Reserve 

System, September 6, 2018. 

Michele Taylor Fennell, 

Assistant Secretary of the Board. 

[FR Doc. 2018–19676 Filed 9–11–18; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than October 8, 

2018. 

A. Federal Reserve Bank of Dallas 

(Robert L. Triplett III, Senior Vice 

President) 2200 North Pearl Street, 

Dallas, Texas 75201–2272: 

1. Veritex Holdings, Inc., Dallas, 

Texas; to acquire Green Bancorp, Inc., 

and thereby indirectly acquire Green 

Bank, National Association, both of 

Houston, Texas. 

Board of Governors of the Federal Reserve 

System, September 7, 2018. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2018–19826 Filed 9–11–18; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Agency Information Collection 

Activities: Announcement of Board 

Approval Under Delegated Authority 

AGENCY: Board of Governors of the 

Federal Reserve System. 

SUMMARY: Notice is hereby given of 

temporary approval of revisions to the 

mandatory Complex Institution 

Liquidity Monitoring Report (FR 2052a; 

OMB No. 7100–0361) by the Board of 

Governors of the Federal Reserve 

System (Board) pursuant to the 

authority delegated to the Board by the 

Office of Management and Budget 

(OMB), per OMB Regulations on 

Controlling Paperwork Burdens on the 

Public. The temporary approval is valid 

until March 31, 2019. 

DATES: The revisions are applicable as of 

June 30, 2018. 

FOR FURTHER INFORMATION CONTACT:

Federal Reserve Board Clearance 

Officer—Nuha Elmaghrabi—Office of 

the Chief Data Officer, Board of 

Governors of the Federal Reserve 

System, Washington, DC 20551, (202) 

452–3829. Telecommunications Device 

for the Deaf (TDD) users may contact 

(202) 263–4869, Board of Governors of 

the Federal Reserve System, 

Washington, DC 20551. 

OMB Desk Officer—Shagufta 

Ahmed—Office of Information and 

Regulatory Affairs, Office of 

Management and Budget, New 

Executive Office Building, Room 10235, 

725 17th Street NW, Washington, DC 

20503 or by fax to (202) 395–6974. 

SUPPLEMENTARY INFORMATION: On June 

15, 1984, OMB delegated to the Board 

authority under the Paperwork 

Reduction Act (PRA) to temporarily 

approve a revision to a collection of 

information without providing 

opportunity for public comment if the 

Board determines that a change in an 

existing collection must be instituted 

quickly and that public participation in 

the approval process would defeat the 

purpose of the collection or 

substantially interfere with the Board’s 

ability to perform its statutory 

obligation. 

The Board’s delegated authority 

requires that the Board, after 

temporarily approving a collection, 

publish a notice soliciting public 

comment. The Board will publish a 

notice in the future inviting comment 

on these actions. 

Final approval under OMB delegated 

authority of the temporary revision of 

the following report: 

Report title: Complex Institution 

Liquidity Monitoring Report. 

Agency form number: FR 2052a. 

OMB control number: 7100–0361. 

Effective Date: June 30, 2018. 

Frequency: Monthly, and each 

business day (daily). 

Respondents: U.S. bank holding 

companies (BHCs), U.S. savings and 

loan holding companies (SLHCs), and 

foreign banking organizations (FBOs) 

with U.S. assets. 

Estimated number of respondents: 

Monthly, 40; Daily, 12. 

Estimated average hours per response: 

Monthly, 120; Daily, 220. 

Estimated annual burden hours: 

717,600. 

General description of report: The FR 

2052a is used to monitor the overall 

liquidity profile of institutions 

supervised by the Board. These data 

provide detailed information on the 

liquidity risks within different business 

lines (e.g., financing of securities 

positions, prime brokerage activities). In 

particular, these data serve as part of the 

Board’s supervisory surveillance 

program in its liquidity risk 

management area and provide timely 

information on firm-specific liquidity 

risks during periods of stress. Analyses 

of systemic and idiosyncratic liquidity 

risk issues are then used to inform the 

Board’s supervisory processes, 

including the preparation of analytical 


daltland on DSKBBV9HB2PROD with NOTICES
46164 Federal Register / Vol. 83, No. 177 / Wednesday, September 12, 2018 / Notices 

1Press Release, Board of Governors of the Federal 

Reserve System, Agencies issue final rule regarding 

the treatment of certain municipal securities as 

high-quality liquid assets (August 22, 2018), 

available at https://www.federalreserve.gov/ 

newsevents/pressreleases/bcreg20180822a.htm. 

reports that detail funding 

vulnerabilities. 

Legal authorization and 

confidentiality: The Board’s Legal 

Division has determined that the FR 

2052a is authorized pursuant to section 

5 of the Bank Holding Company Act (12 

U.S.C. 1844), section 8 of the 

International Banking Act (12 U.S.C. 

3106), and section 165 of the DoddFrank Wall Street Reform and Consumer 

Protection Act (Dodd-Frank Act) (12 

U.S.C. 5365) and are mandatory. Section 

5(c) of the Bank Holding Company Act 

authorizes the Board to require BHCs to 

submit reports to the Board regarding 

their financial condition. Section 8(a) of 

the International Banking Act subjects 

FBOs to the provisions of the Bank 

Holding Company Act. Section 165 of 

the Dodd-Frank Act requires the Board 

to establish prudential standards for 

certain BHCs and FBOs, which include 

liquidity requirements. 

Financial institution information 

required by the FR 2052a is collected as 

part of the Board’s supervisory process. 

Therefore, such information is entitled 

to confidential treatment under 

Exemption 8 of the Freedom of 

Information Act (FOIA) (5 U.S.C. 

552(b)(8)). In addition, the institution 

information provided by each 

respondent would not be otherwise 

available to the public and its disclosure 

could cause substantial competitive 

harm. Accordingly, it is entitled to 

confidential treatment under the 

authority of exemption 4 of the FOIA (5 

U.S.C. 552(b)(4)), which protects from 

disclosure trade secrets and commercial 

or financial information. 

Current Actions: The Economic 

Growth, Regulatory Relief, and 

Consumer Protection Act (EGRRCPA), 

enacted on May 24, 2018, amended 

various provisions of banking law to 

eliminate or reduce statutory and 

regulatory requirements on certain 

banking organizations. Section 403 of 

EGRRCPA provides that the federal 

banking agencies shall treat certain 

municipal obligations as ‘‘high quality 

liquid assets’’ (HQLA) for purposes of 

their liquidity regulations, and must 

amend those regulations to reflect this 

new treatment within 90 days of the 

enactment of EGRRCPA. The federal 

banking agencies, on August 22, 2018, 

issued an interim final rule 1 amending 

their liquidity regulations (the 

‘‘Liquidity IFR’). The current FR 2052a 

instructions are inconsistent with the 

provisions of EGRRCPA. The Board has 

revised the FR 2052a to provide that 

respondents are permitted to report 

investment grade municipal obligations 

as HQLA, consistent with EGRRCPA 

and the Liquidity IFR. In order for the 

FR 2052a to reflect section 403 of 

EGRRCPA, which became effective 

immediately when EGRRCPA was 

signed on May 24, 2018, the Board 

cannot comply with the normal 

clearance process and still receive the 

June 30, 2018, financial data in a timely 

manner. Therefore, the Board has 

determined that the revision to the FR 

2052a described above must be 

instituted quickly and public 

participation in the approval process 

would substantially interfere with the 

Board’s ability to perform its statutory 

obligations arising from EGRRCPA. 

Board of Governors of the Federal Reserve 

System, September 6, 2018. 

Michele Taylor Fennell, 

Assistant Secretary of the Board. 

[FR Doc. 2018–19675 Filed 9–11–18; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RETIREMENT THRIFT 

INVESTMENT BOARD 

Board Meeting; 77 K St. NE, 

Washington, DC; 10th Floor; 

September 17, 2018; 8:30 a.m. 

Open Session 

1. Approval of the Minutes of the 

August 27, 2018 Board Meeting 

2. Monthly Reports 

(a) Participant Activity 

(b) Investment Policy 

(c) Legislative Report 

3. FY 19 Budget Review and Approval 

4. Vendor Risk Management Update 

5. Capital Market and L Fund Update 

6. IT Update 

Closed Session 

Information covered under 5 U.S.C. 

552b(c)(4) and (c)(9)(B). 

CONTACT PERSON FOR MORE INFORMATION: 

Kimberly Weaver, Director, Office of 

External Affairs, (202) 942–1640. 

Dated: September 7, 2018. 

Dharmesh Vashee, 

Deputy General Counsel, Federal Retirement 

Thrift Investment Board. 

[FR Doc. 2018–19833 Filed 9–11–18; 8:45 am] 

BILLING CODE 6760–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0908] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Guidance for 

Clinical Trial Sponsors: Establishment 

and Operation of Clinical Trial Data 

Monitoring Committees 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by October 12, 

2018. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, Fax: 202– 

395–7285, or emailed to oira_

submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0581. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

JonnaLynn Capezzuto, Office of 

Operations, Food and Drug 

Administration, Three White Flint 

North, 10A–12M, 11601 Landsdown St., 

North Bethesda, MD 20852, 301–796– 

3794, PRAStaff@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Guidance for Clinical Trial Sponsors: 

Establishment and Operation of 

Clinical Trial Data Monitoring 

Committees 

OMB Control Number 0910–0581— 

Extension 

Sponsors are required to monitor 

studies evaluating new drugs, biologics, 

and devices (21 CFR 312.50 and 312.56 

for drugs and biologics, and 21 CFR 

812.40 and 812.46 for devices). Various 

individuals and groups play different 

roles in clinical trial monitoring. One 


daltland on DSKBBV9HB2PROD with NOTICES